OrbusNeich Medical Group Holdings Limited (FRA:Q8T)
Germany · Delayed Price · Currency is EUR 0.3500
-0.0200 (-5.41%)
At close: Jan 28, 2026
FRA:Q8T Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 40.67 | 39.72 | 45.07 | 18.49 | -4.44 | 7.07 |
Depreciation & Amortization | 5.12 | 4.85 | 3.77 | 3.5 | 3.67 | 3.96 |
Other Amortization | 0.45 | 0.45 | 0.43 | 0.38 | 0.35 | 0.13 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.05 | 0.03 | 0.08 | -0.01 |
Asset Writedown & Restructuring Costs | 1.57 | 1.57 | - | 0.34 | - | - |
Loss (Gain) From Sale of Investments | 0.63 | 0.63 | -0.92 | 1.74 | -0.06 | -0.82 |
Loss (Gain) on Equity Investments | 1.71 | 1.71 | 0.84 | 0.2 | 0.21 | 0.05 |
Stock-Based Compensation | 1.07 | 1.07 | 1.08 | 0.68 | 1.34 | - |
Other Operating Activities | -19.42 | -13.39 | -9.35 | 2.82 | 22.9 | -0.53 |
Change in Accounts Receivable | -5.73 | -5.73 | -1.74 | -7.57 | -1.72 | 8.64 |
Change in Inventory | -17.19 | -17.19 | -6.84 | -2.5 | -1.59 | -1.93 |
Change in Accounts Payable | 2.08 | 2.08 | -2.74 | 1.91 | 0.84 | -2.19 |
Change in Other Net Operating Assets | -2.72 | -2.72 | -6.62 | 3.41 | -1.08 | -1.7 |
Operating Cash Flow | 8.31 | 13.11 | 23.03 | 23.43 | 20.5 | 12.67 |
Operating Cash Flow Growth | -55.99% | -43.06% | -1.70% | 14.31% | 61.83% | 696.60% |
Capital Expenditures | -9.91 | -9.8 | -5.6 | -2.9 | -1.25 | -0.94 |
Sale of Property, Plant & Equipment | 0.08 | 0.07 | 0.49 | 0.12 | 0.22 | 0.11 |
Cash Acquisitions | -1.28 | - | -13.19 | - | - | -2.24 |
Divestitures | - | - | - | - | - | -0.04 |
Sale (Purchase) of Intangibles | -2 | -1.42 | -0.4 | -0.44 | -0.89 | -2.81 |
Investment in Securities | 62.29 | 7.27 | -37.77 | -166.75 | -3.31 | -5.33 |
Other Investing Activities | 13.05 | 12.53 | 4.15 | 0.65 | 0.01 | 0.01 |
Investing Cash Flow | 62.22 | 8.65 | -52.32 | -169.32 | -5.22 | -11.25 |
Short-Term Debt Issued | - | - | 4.24 | 5 | 3.06 | 4.51 |
Long-Term Debt Issued | - | - | - | - | 0.23 | 5.13 |
Total Debt Issued | - | - | 4.24 | 5 | 3.29 | 9.64 |
Short-Term Debt Repaid | - | -4.24 | - | -5 | -42.96 | -3.41 |
Long-Term Debt Repaid | - | -2.11 | -1.84 | -1.42 | -11.71 | -5.37 |
Total Debt Repaid | -6.47 | -6.35 | -1.84 | -6.42 | -54.67 | -8.78 |
Net Debt Issued (Repaid) | -6.47 | -6.35 | 2.4 | -1.42 | -51.38 | 0.86 |
Issuance of Common Stock | - | - | 0.18 | 61.64 | - | - |
Repurchase of Common Stock | -1.06 | -1.78 | -0.82 | - | - | - |
Common Dividends Paid | -10.61 | -10.62 | - | - | - | - |
Other Financing Activities | -0.21 | -0.22 | -0.88 | -2.77 | -1.28 | -1.34 |
Financing Cash Flow | -18.35 | -18.96 | 0.88 | 57.44 | 146.31 | -0.47 |
Foreign Exchange Rate Adjustments | 2.28 | -1.39 | 0.01 | -0.8 | -0.81 | 0.53 |
Net Cash Flow | 54.46 | 1.41 | -28.39 | -89.24 | 160.77 | 1.48 |
Free Cash Flow | -1.6 | 3.32 | 17.43 | 20.53 | 19.25 | 11.72 |
Free Cash Flow Growth | - | -80.97% | -15.11% | 6.66% | 64.22% | - |
Free Cash Flow Margin | -0.95% | 2.02% | 11.33% | 15.01% | 16.53% | 13.25% |
Free Cash Flow Per Share | -0.00 | 0.00 | 0.02 | 0.03 | 0.03 | 0.02 |
Cash Interest Paid | 0.21 | 0.22 | 0.14 | 0.13 | 0.75 | 1.34 |
Cash Income Tax Paid | 7.14 | 6.63 | 3.6 | 1.98 | 1.85 | - |
Levered Free Cash Flow | -15.14 | -4.46 | 5.32 | 15.56 | 12.32 | -84.13 |
Unlevered Free Cash Flow | -15.01 | -4.33 | 5.41 | 16.47 | 15.83 | -83.25 |
Change in Working Capital | -23.55 | -23.55 | -17.94 | -4.75 | -3.54 | 2.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.